Read more about Indian Defence has a Sputnik Moment as it adopts artificial intelligence on Business Standard. The new-generation platforms of the Indian Navy give it an edge in developing new AI technologies that are becoming increasingly popular with military and industry
COVID-19 drug 2-DG not for everyone, DRDO issues directions for usage
COVID-19 drug 2-DG not for everyone, DRDO issues directions for usage
The drug could be a game-changer in the battle against the pandemic as it helps in faster recovery of hospitalised patients.
Share
Updated: Jun 1, 2021, 11:48 PM IST
The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on the usage of the new COVID-19 drug 2-DG.
The DRDO said that patients with uncontrolled diabetes, severe cardiac problem, acute respiratory distress syndrome (ARDS), severe hepatic and renal impairment should be cautious before taking this medicine. The drug can be given to patients under the care and prescription of doctors, DRDO said.
J&K Lieutenant Governor Manoj Sinha inaugurated a 500-bed dedicated Covid facility set up by the DRDO in Jammu to help the Union Territory deal effectively with the Covid-19 pandemic.
LG Manoj Sinha dedicates DRDO s 500-bedded COVID hospital in J-K to people ANI | Updated: May 29, 2021 17:20 IST
Jammu (Jammu and Kashmir) [India], May 29 (ANI): Strengthening healthcare facilities in Jammu and Kashmir amid the second wave of the COVID-19, Lieutenant General Manoj Sinha on Saturday dedicated a 500-bedded hospital by the Defence Research and Development Organisation (DRDO) to the public.
According to an official, the 500-bedded hospital dedicated to the public in Jammu today and another hospital will be set up in Kashmir soon.
In order to meet the growing need for beds in the Union Territory (UT), the DRDO had started working on two such projects in the region, completing the 500-bedded facility at a COVID hopsital in Jammu within a period of 3 weeks.
Highlights
2-DG anti-COVID-19 drug price has been fixed at Rs 990 per sachet.
Union Defence Minister Rajnath Singh said that 10,000 sachets of 2-DG will be available in the market from Thursday (May 27).
earlier, Dr Reddy s had stated that the anti-COVID-19 drug is expected to launch in the market by mid-June.
New Delhi: Dr Reddy’s has fixed the price of DRDO’s 2-deoxy-D-glucose (2-DG) anti-COVID-19 drug at Rs 990 per sachet.
The price of DRDO’s 2DG anti-COVID 19 drug has been kept at Rs 990 per sachet by Dr Reddy’s lab. Govt hospitals, central and state govt would be provided the medicine at a discounted price: Govt officials pic.twitter.com/FEic70fSq5